Do you want to read an article? Please log in or register.
The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients
Inflammatory Bowel Disease
Related content
COMMENTED
Inflammatory Bowel Disease
Genetic risk factors predict disease progression in Crohn's disease patients of the Swiss inflammatory bowel disease cohort
★ 2
Recommended and commented by
Prof. Dr Stephan Vavricka, Faculty Member
Therap Adv Gastroenterol
Ditrich F, Blümel S, Biedermann L, Fournier N, Rossel JB, Ellinghaus D, Franke A, Stange EF, Rogler G, Scharl M, Swiss IBD Cohort Study Group.
doi: 10.1177/1756284820959252
Inflammatory Bowel Disease
The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort
Inflamm Bowel Dis.
Madanchi M, Fagagnini S, Fournier N, Biedermann L, Zeitz J, Battegay E, Zimmerli L, Vavricka SR, Rogler G, Scharl M; Swiss IBD Cohort Study Group.
doi: 10.1093/ibd/izy054.
Inflammatory Bowel Disease
Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study
PLoS One.
Roth N, Biedermann L, Fournier N, Butter M, Vavricka SR, Navarini AA, Rogler G, Scharl M; Swiss IBD Cohort Study Group
doi: 10.1371/journal.pone.0210436.
Inflammatory Bowel Disease
Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study
Am J Gastroenterol.
Scharl S, Barthel C, Rossel JB, Biedermann L, Misselwitz B, Schoepfer AM, Straumann A, Vavricka SR, Rogler G, Scharl M, Greuter T
doi: 10.1038/s41395-018-0360-9.
Inflammatory Bowel Disease
Genetic effects on the commensal microbiota in inflammatory bowel disease patients
PLoS Genet.
Aschard H, Laville V, Tchetgen ET, Knights D, Imhann F, Seksik P, Zaitlen N, Silverberg MS, Cosnes J, Weersma RK, Xavier R, Beaugerie L, Skurnik D, Sokol H
doi: 10.1371/journal.pgen.
Gastrointestinal DiseasesInflammatory Bowel Disease
Genotype-phenotype associations of polymorphisms within the gene locus of NOD-like receptor pyrin domain containing 3 in Swiss inflammatory bowel disease patients
BMC Gastroenterol
Yoganathan P, Rossel JB, Jordi SBU, Franc Y, Biedermann L, Misselwitz B, Hausmann M, Rogler G, Scharl M, Frey-Wagner I, Swiss IBD cohort study group.
doi: 10.1186/s12876-021-01880-9
Inflammatory Bowel Disease
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease
JAMA.
Walker GJ, Harrison JW, Heap GA, Voskuil MD, Andersen V, Anderson CA, Ananthakrishnan AN, Barrett JC, Beaugerie L, Bewshea CM, Cole AT, Cummings FR, Daly MJ, Ellul P, Fedorak RN, Festen EAM, Florin TH, Gaya DR, Halfvarson J, Hart AL, Heerasing NM, Hendy P, Irving PM, Jones SE, Koskela J, Lindsay JO, Mansfield JC, McGovern D, Parkes M, Pollok RCG, Ramakrishnan S, Rampton DS, Rivas MA, Russell RK, Schultz M, Sebastian S, Seksik P, Singh A, So K, Sokol H, Subramaniam K, Todd A, Annese V, Weersma RK, Xavier R, Ward R, Weedon MN, Goodhand JR, Kennedy NA, Ahmad T; IBD Pharmacogenetics Study Group
doi: 10.1001/jama.2019.0709.
Inflammatory Bowel Disease
A SNP within the gene locus of the oxysterol receptor EBI2 is associated with EBI2 expression on blood lymphocytes in patients with IBD
Br J Pharmacol
Ruiz F, Wyss A, Rossel JB, Sulz MC, Brand S, Moncsek A, Mertens JC, Roth R, Clottu A, Burri E, Juillerat P, Biedermann L, Greuter T, Rogler G, Pot C, Misselwitz B, Swiss IBD Cohort Study Group.
doi: 10.1111/bph.15395
Celiac DiseaseGastrointestinal DiseasesGastritisGastroesophageal Reflux Disease (GERD)Minimally Invasive Gastrointestinal SurgeryFurther Publications
Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study
PloS One.
Bon L, Scharl S, Vavricka S, Rogler G, Fournier N, Pittet V, Scharl M, Greuter T, Schreiner P, Frei P, Misselwitz B, Biedermann L, Zeitz J, Swiss IBD Cohort Study Group.
doi: 10.1371/journal.